肝癌的现代综合治疗(附1320例报告)

Modern multi modality therapy for liver cancer:a report of 1320 cases

１９８６年１月至１９９５年１２月，对１３２０例肝癌病人行外科治疗，其中行各类肝切除术６８０例（手术切除率５１．５％），肝切除术后１、３、５年生存率为９０．４％、５２．４％、３３％。术中肿瘤未能切除者均行外科综合治疗，主要包括肝动脉插管、１２５Ｉ或１３１Ｉ－碘油－抗癌药物导向治疗、术中无水酒精瘤体内注入术、术后介入治疗、化疗和生物疗法等，术后１、３、５年生存率为５２．６％、１８．４％、６．４％。着重讨论肝切除在肝癌综合治疗中的地位，强调现代综合治疗的作用，并对大肝癌及复发性肝癌行综合治疗后再切除等问题进行了讨论。

Modern multi modality therapy for liver cancer.Wang Xuehao,Du Jinghui,Zhao Zhongxing,et al.The First Affiliated Hospital of Nanjing Medical University,Naijing 210029 From January 1986 to December 1995,1320 cases with liver cancer were operated on,with a resectability of 51 5%(680 cases).Of the 680 cases,the overall 1 3 5 year survival rates were 90 4% 52 4% 33% respectively.Surgical multimodalities therapy was carried out in unresectable cases,including hepatic arterial infusion 125 I or 131 I lipiodl anticancer drug targeting therapy injecting into neoplasm with anhydous alcohol interventional treatmemt after surgery chemotherapy and biotherapy and so on,with the results of 1 3 5 year survival rates of 52 6% 18 4% 6 4% respectively.The auther indicated the statue of the liver resection in liver cancer treatment,and emphosized on the function of the modern multimodalities therapy,and then discussed the problems about the large liver cancer and resection of the recurrent hepatic cancer after multimodalities therapy.